IRINOTECAN APOTEX irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection via

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Aktivna sestavina:

irinotecan hydrochloride trihydrate, Quantity: 40 mg

Dostopno od:

Baxter Healthcare Pty Ltd

INN (mednarodno ime):

irinotecan hydrochloride trihydrate

Farmacevtska oblika:

Injection, concentrated

Sestava:

Excipient Ingredients: water for injections; lactic acid; sorbitol; sodium hydroxide; hydrochloric acid

Pot uporabe:

Intravenous Infusion

Enote v paketu:

1

Tip zastaranja:

(S4) Prescription Only Medicine

Terapevtske indikacije:

Irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. Irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Povzetek izdelek:

Visual Identification: Sterile, pale yellow, clear, aqueous solution; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status dovoljenje:

Licence status A

Datum dovoljenje:

2016-05-23